Progyny, Inc. Financials

Market Capitalization $1.84 Billion as of July 1, 2025

Valuations Metrics as of Jul. 5, 2025

Trailing PE	37.65
Forward PE	28.24
Price to Sales TTM	$1.52
Price to Book MRQ	$3.91
Enterprise to Revenue	1.37
Enterprise to EBITDA	21.63

Financial Reports as of Mar. 31, 2025

Financials

Fiscal Year Ends	2024-12-31
Most Recent Quarter	2025-03-31
Profit Margin	4.33%
Operating Margin	7.46%
Return on Assets TTM	5.99%
Return on Equity TTM	10.11%

Income Statement

Revenue TTM	$1,213,181,056
Revenue per Share TTM	$13.67
Quarterly Revenue Growth	16.50%
Gross Profit TTM	$266,752,000
EBITDA	$76,669,000
Net Income to Common TTM	$52,497,000
Diluted EPS TTM	$0.57
Quarterly Earnings Growth YoY	-10.90%

Balance Sheet

Total Cash MRQ	$256,123,008
Total Cash per Share MRQ	$2.99
Total Debt MRQ	$
Total Debt to Equity MRQ	6.19
Current Ratio MRQ	2.39
Book Value per Share MRQ	$5.49

Cash Flow

Operating Cash Flow TTM	$203,180,992
Levered Free Cash Flow TTM	$200,378,752

PGNY Stock Info as of Jul. 5, 2025

Stock Statistics

Shares Outstanding	85,310,698
Float Shares	79,364,609
Avg 10 Volume	1,230,040
Avg 30 Volume	None
Shares Short	6,625,645
Short Ratio	6.73
Short % of Shares	10.71%
% Held by Insiders	7.64%
% Held by Institutions	98.36%

Stock Price Summary

Beta	1.32
Fifty Two Week Low	$13.39
Fifty Two Week High	$30.42
Fifty Two Week Change	-32.53%
Day 50 MA	$21.86
Day 200 MA	$19.59

Dividends and Splits

Forward Annual Dividend Rate	$
Forward Annual Dividend Yield	%
Trailing Annual Dividend Rate	$0.00
Trailing Annual Dividend Yield	0.00%
Payout Ratio	0.00%
Dividend Date
Ex Dividend Date
Last Split Factor
Last Split Date